Palatin Technologies Inc (PTN) (Q1 2027) Earnings Call Highlights: Advancing Next-Generation ...
Palatin Technologies Inc (PTN) outlined progress on its lipidated MC4R peptide with Phase 1 targeted for the first half of 2027, while reporting a $5.1 million quarterly net loss and $3.7 million in Related Stocks: PTN ,